shortagewatch

Home / Companies / Fresenius Kabi

Company family · HQ DE

Fresenius Kabi: medicine shortages

FRE · Xetra

As of 2 Nov 2026, 339 Fresenius Kabi products have a reported shortage across 12 countries, covering 81 medicines.

Products short339rank #8 of 464
Medicines81active ingredients
Countries12/16
New in 90 days60-1 vs market pace
Typical duration23 monthsmedian so far
Manufacturing34%demand-driven 31%

Where

United States188Canada10Germany12Italy50Spain18Ireland2Austria13Belgium9Switzerland1Czechia20Norway5Sweden11

Which therapeutic classes

Nervous system89Blood78Cancer and immune system29Cardiovascular system27Anti-infectives23Musculoskeletal system23Digestive tract and metabolism14Various11Systemic hormones2

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Fresenius KabiFresenius Kabi: Manufacturing problem 62 (18%)18%Fresenius Kabi: Increased demand 57 (17%)17%Fresenius Kabi: Active ingredient shortage 1 (0%)Fresenius Kabi: Distribution or logistics 37 (11%)11%Fresenius Kabi: Commercial decision or withdrawal 1 (0%)Fresenius Kabi: Regulatory or licensing 1 (0%)Fresenius Kabi: Other 21 (6%)6%Fresenius Kabi: Not stated 158 (47%)47%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes
DateCountryMedicineChange
2 NovDEGranisetron
Granisetron Kabi 1 mg/ml Konzentrat zur Herstellung einer Injektionslösung/Infusionslösung		new shortage (back 14 Dec)
2 NovDEFat Emulsions
SMOFlipid 200 mg/ml Emulsion zur Infusion		new shortage (back 31 Dec)

Open shortages over time

979810010131 Oct2026-10-31: 981 Nov2026-11-01: 982 Nov2026-11-02: 100

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

06121825Dec: 3Jan ’25: 1Feb: 0FebMar: 7Apr: 3May: 2MayJun: 0Jul: 4Aug: 1AugSep: 0Oct: 1Nov: 2NovDec: 8Jan ’26: 10Feb: 11FebMar: 14Apr: 6May: 6MayJun: 13Jul: 11Aug: 19AugSep: 18Oct: 21Nov: 4Nov

Long-run trend in Canada

Canada dashboard
02550751002017: 1720172018: 2620182019: 3220192020: 3720202021: 6220212022: 9220222023: 2920232024: 3520242025: 3720252026: 272026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Jamp151

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaApotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Fresenius Kabi: 339 / 81Fresenius Kabi

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Ropivacaine2923 Mar 2018Not stated9/16
Lidocaine2022 Feb 2012Not stated2/16
Electrolytes148 Oct 2023Increased demand8/16
Tocilizumab1219 Aug 2024Increased demand5/16
Bupivacaine1020 Feb 2018Not stated8/16
Hydromorphone1031 Oct 2017Not stated5/16
Amino Acids823 Dec 2025Increased demand5/16
Carbohydrates816 Mar 2025Not stated7/16
Glucose814 Feb 2022Not stated1/16
Dexamethasone78 Feb 2019Not stated1/16
Ketorolac723 Mar 2018Other4/16
Midazolam72 Apr 2020Not stated7/16
Rocuronium Bromide715 Feb 2023Distribution or logistics5/16
Fat Emulsions612 Dec 2024Manufacturing problem4/16
Fentanyl61 Jan 2012Not stated7/16
Morphine631 Oct 2017Not stated8/16
Calcium Acetate and Magnesium Carbonate518 Mar 2025Manufacturing problem5/16
Ciprofloxacin520 May 2026Manufacturing problem9/16
Dexmedetomidine410 Apr 2020Distribution or logistics4/16
Mannitol419 Jan 2025Not stated2/16
Zoledronic Acid42 Jul 2026Manufacturing problem7/16
Alanyl Glutamine31 Jun 2026Manufacturing problem3/16
Carboplatin328 Apr 2023Distribution or logistics10/16
Caspofungin312 Jan 2026Not stated5/16
Clindamycin34 Sep 2026Increased demand9/16
Combinations322 Oct 2026Distribution or logistics2/16
Fluconazole331 Oct 2024Manufacturing problem12/16
Furosemide37 Apr 2020Not stated11/16
Heparin314 Nov 2017Not stated5/16
Propofol312 Dec 2025Manufacturing problem6/16
Remifentanil328 Jun 2022Not stated5/16
Adalimumab21 Sep 2026Manufacturing problem8/16
Benzylpenicillin22 Oct 2026Manufacturing problem4/16
Calcium Folinate220 Jul 2026Manufacturing problem7/16
Cefepime210 Feb 2026Not stated2/16
Dexamethasone28 Feb 2019Increased demand10/16
Diclofenac, Combinations210 Aug 2026Increased demand1/16
Granisetron211 Dec 2025Other7/16
Haloperidol29 Jan 2026Not stated4/16
Icatibant27 May 2026Not stated8/16
Levobupivacaine211 Dec 2025Manufacturing problem2/16
Methotrexate213 Mar 2023Not stated6/16
Oxaliplatin225 Feb 2026Not stated10/16
Paracetamol213 Mar 2023Increased demand10/16
Piperacillin and Beta-Lactamase Inhibitor220 Jan 2026Not stated8/16
Sodium Bicarbonate224 Jul 2017Not stated2/16
Adenosine128 Jun 2026Not stated5/16
Ammonium Chloride11 Nov 2026Not stated1/16
Arsenic Trioxide121 Sep 2026Not stated2/16
Atropine11 Jan 2012Other5/16
Azacitidine118 Dec 2020Manufacturing problem6/16
Bendamustine16 Oct 2026Not stated7/16
Busulfan111 Sep 2026Manufacturing problem3/16
Ceftriaxone127 Oct 2026Manufacturing problem5/16
Denosumab121 Sep 2026Increased demand2/16
Electrolytes with Carbohydrates130 Jun 2026Commercial decision or withdrawal5/16
Flumazenil131 May 2026Manufacturing problem1/16
Foscarnet11 Mar 2025Manufacturing problem2/16
Fulvestrant114 Aug 2026Not stated5/16
Gelatin Agents14 Mar 2026Manufacturing problem2/16
Hypertonic Solutions122 Jan 2026Not stated1/16
Ifosfamide112 Jun 2026Increased demand12/16
Lacosamide12 Nov 2026Distribution or logistics6/16
Lidocaine15 Aug 2025Manufacturing problem9/16
Lorazepam13 May 2018Not stated5/16
Melphalan116 Sep 2026Not stated4/16
Metronidazole119 Mar 2026Manufacturing problem5/16
Milrinone122 Oct 2026Other3/16
Norepinephrine127 Nov 2026Not stated5/16
Orphenadrine, Combinations117 Jun 2026Distribution or logistics1/16
Palonosetron110 Dec 2024Manufacturing problem5/16
Pamidronic Acid1not givenNot stated3/16
Pantoprazole1not givenNot stated9/16
Plerixafor113 Mar 2026Not stated7/16
Propranolol131 Oct 2023Distribution or logistics7/16
Sodium Acetate123 Mar 2016Other1/16
Solutions Affecting The Electrolyte Balance13 Feb 2026Not stated1/16
Sultiame128 Oct 2026Manufacturing problem1/16
Thiamine (Vit B1)121 Oct 2026Distribution or logistics3/16
Trometamol126 Oct 2026Regulatory or licensing1/16
Valproic Acid130 Dec 2020Increased demand10/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.